New hair loss drug combo enters human trials
Disease control
Not yet recruiting
This early-stage trial tests a topical gel (AD-303A) and an oral pill (AD-3031) in 30 men aged 19–55 with male pattern baldness. The goal is to see how the drug moves through the body and if it is safe. The study is not yet recruiting and will help choose the right dose for futur…
Phase: PHASE1, PHASE2 • Sponsor: Moogene Medi Co., Ltd • Aim: Disease control
Last updated May 13, 2026 16:02 UTC